Gute Therapieverträglichkeit und Lebensqualität nach primär organerhaltender Therapie des frühen Rektumkarzinoms: Ergebnisse der TREC-StudieGood treatment tolerability and quality of life after primary organ-preserving therapy of early-stage rectal cancer: results of the TREC study

[1] Aquina CT(2017)The impact of age on complications, survival, and cause of death following colon cancer surgery Br J Cancer 116 389-397

[2] Mohile SG(2021)Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study Lancet Gastroenterol Hepatol 6 92-105

[3] Tejani MA(2022)Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Clin Oncol 40 2546-2556

[4] Bach SP(2022)Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision Lancet Healthy Longev 3 e825-38

[5] Gilbert A(2019)Cancer treatment and survivorship statistics, 2019 CA A Cancer J Clin 69 363-385

[6] Brock K(2018)Personalized management of elderly patients with rectal cancer: expert recommendations of the European society of surgical oncology, European society of Coloproctology, international society of geriatric oncology, and American college of surgeons commission on cancer Eur J Surg Oncol 44 1685-1702

[7] Garcia-Aguilar J(2022)Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer—the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial Trials 23 948-501

[8] Patil S(2008)Controversies of total mesorectal excision for rectal cancer in elderly patients Lancet Oncol 9 494-53

[9] Gollub MJ(2016)Recurrence in patients with stage I colorectal cancer ANZ J Surg 86 49-1730

[10] Gilbert A(2020)Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment Br J Surg 107 1719-undefined

[1] Aquina CT(2017)The impact of age on complications, survival, and cause of death following colon cancer surgery Br J Cancer 116 389-397

[2] Mohile SG(2021)Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study Lancet Gastroenterol Hepatol 6 92-105

[3] Tejani MA(2022)Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Clin Oncol 40 2546-2556

[4] Bach SP(2022)Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision Lancet Healthy Longev 3 e825-38

[5] Gilbert A(2019)Cancer treatment and survivorship statistics, 2019 CA A Cancer J Clin 69 363-385

[6] Brock K(2018)Personalized management of elderly patients with rectal cancer: expert recommendations of the European society of surgical oncology, European society of Coloproctology, international society of geriatric oncology, and American college of surgeons commission on cancer Eur J Surg Oncol 44 1685-1702

[7] Garcia-Aguilar J(2022)Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer—the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial Trials 23 948-501

[8] Patil S(2008)Controversies of total mesorectal excision for rectal cancer in elderly patients Lancet Oncol 9 494-53

[9] Gollub MJ(2016)Recurrence in patients with stage I colorectal cancer ANZ J Surg 86 49-1730

[10] Gilbert A(2020)Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment Br J Surg 107 1719-undefined